#65 Tony Keating - Co-Founder of ResApp
Manage episode 409172883 series 3498379
ResApp is a biotech company that commercialised technology to diagnose respiratory illnesses based on an audio recording of a patient’s cough on their phone. After proving immensely useful for diagnosing COVID-19 during the height of pandemic, Pfizer acquired the company for $180 million.
Throughout the episode, Tony discusses the path of listing on the ASX early-on and how that provided the initial capital needed for the company to succeed. Coming from a research background, Tony also talks about how his experience as a scholar and background in engineering contributes to being an effective CEO.
If you enjoy this episode, feel free to share with family and friends and leave a 5 star review.
Share the episode: https://thedionguagliardopodcast.buzzsprout.com/share
More on us!
Dion's Newsletter: http://eepurl.com/hHg1ff
Our social media: https://linktr.ee/FortressFinancial
Fortress Family Office: https://www.fortressfamilyoffice.com/
Contact us: admin@fortressfamilyoffice.com
Bab
1. Highlight Clip (00:00:00)
2. Introduction (00:00:41)
3. Guest Background and Introduction (00:02:09)
4. Why did Tony Keating List ResApp on the ASX (00:02:52)
5. What is ResApp and The Journey So Far (00:04:51)
6. Was Tony Keating Always Entrepreneurial? (00:07:11)
7. What Advantages does Tony's Engineering Give Him as CEO (00:10:47)
8. Who did Tony Keating Turn To in Times of Need? (00:18:22)
9. Tony Keating's Biggest Strength and How it Helped Him Succeed with ResApp (00:19:13)
10. What was the Biggest Learning Tony Keating had when Leading ResApp (00:19:39)
11. Most Difficult Point for Tony Keating in the ResApp Journey (00:22:35)
12. How Tony Keating Manged ResApp Staff Morale During Tough Times (00:26:12)
13. The Best Advice Tony Keating was Given for ResApp (00:30:15)
14. Tony Keating's Biggest Inspirations (00:31:48)
15. The Business Books that Taught Tony Keating Success (00:33:20)
16. Outtro (00:35:54)
88 episod